DOLOMITE NEAT ID Network Study: A prospective, multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women (208759)

30/05/2018
17/09/2025
EU PAS number:
EUPAS24237
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-208759-protocol-redact

English (249.71 KB - PDF) View document
Updated protocol

viiv-208759-protocol1-redact

First published: 22/02/2024
English (1.55 MB - PDF) View document
Study results
Study report
Other information